期刊文献+

麻疹疫苗联合CHOP方案治疗弥漫大B细胞淋巴瘤的临床研究 被引量:1

Clinical study of measles vaccine combined with CHOP regimen in the treatment of diffuse large B cell lymphoma
下载PDF
导出
摘要 目的:探讨麻疹疫苗(measles vaccine)联合CHOP方案治疗弥漫大B细胞淋巴瘤(DLBCL)的临床疗效和毒副反应。方法:选择2006年1月至2011年12月住院治疗的DLBCL患者60例,随机分为观察组(30例)和对照组(30例),观察组采用麻疹疫苗联合CHOP方案治疗,对照组采用单纯CHOP方案化疗。全部患者完成6个周期化疗。比较两组治疗效果,随访观察生存情况。结果:观察组总有效(OR)率(CR+PR)为83.3%(25/30),对照组总有效(OR)率(CR+PR)为60%(18/30),比较差异有显著性(P<0.05)。观察组和对照组1年PFS率为76.7%及50%(P<0.05),1年总生存率为90%及66.7%(P<0.05)。结论:麻疹疫苗联合CHOP方案治疗弥漫大B细胞淋巴瘤有安全、有效、不良反应少、生存率高等优点,值得进一步研究。 Objective:To evaluate the efficacy and toxicity of combination chemotherapy consisting of lneasles vac- cine and CHOP for patients with diffuse large B - cell lylnpholna(DLBCL). Methods:All 60 patients with DLBCL hospitalized froln January 2006 to Deeelnber 2011 were randomly assigned to receive either CHOP plus lneasles vac- cine (study group) or CHOP alone ( control group). All of the patients have received 6 chemotherapy cycles. Results : The overall respone (OR) rate was 83.3% (25/30) in the study group,and the OR rate was 60% (18/30) in the control group,with an obvious difference between the two groups (P 〈 0.05). The 1 - year progression free survial were 76.7% and 50% in two groups (P 〈 0.05 ). The 1 -year overall ssurvial rates were 90% and 66.7 % in two groups ( P 〈 0.05 ). Conclusion : Combination chemotherapy including measles vaccine and CHOP is effecitive and safe in treatment for DLBCL,fewer adverse reactions,and a higher survival rate.
出处 《现代肿瘤医学》 CAS 2014年第3期643-645,共3页 Journal of Modern Oncology
基金 山东省重点科技计划项目(编号:2006GG2302008)
关键词 麻疹疫苗 弥漫大B细胞淋巴瘤 化疗 measles vaccine diffuse large B - cell lympholna chemotherapy
  • 相关文献

参考文献6

二级参考文献34

共引文献86

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部